1. Allogene Therapeutics Appoints Deborah M. Messemer, Former KPMG Managing Partner, to Its Board

    Allogene Therapeutics Appoints Deborah M. Messemer, Former KPMG Managing Partner, to Its Board

    “I was drawn to this opportunity to serve on Allogene's Board of Directors because of its life-changing mission and its world-class management team ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. Debbie is a seasoned executive with deep financial and audit experience. She also served as the senior account executive for some of KPMG's largest and most prominent clients.
    2. I was drawn to this opportunity to serve on Allogene's Board of Directors because of its life-changing mission and its world-class management team that has demonstrated the ability to innovate cutting-edge cancer therapies.
  3. Topics Mentioned